10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 273 filers reported holding 10X GENOMICS INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $568 | -13.8% | 13,789 | +16.8% | 0.00% | 0.0% |
| Q2 2023 | $659 | -98.8% | 11,803 | +1541.6% | 0.00% | – |
| Q1 2022 | $54,000 | -49.5% | 719 | 0.0% | 0.00% | – |
| Q4 2021 | $107,000 | +2.9% | 719 | 0.0% | 0.00% | – |
| Q3 2021 | $104,000 | -25.7% | 719 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $140,000 | -88.8% | 719 | -89.6% | 0.00% | -80.0% |
| Q1 2021 | $1,247,000 | +32.8% | 6,891 | +3.8% | 0.01% | +25.0% |
| Q4 2020 | $939,000 | +19.3% | 6,636 | +5.0% | 0.00% | +33.3% |
| Q3 2020 | $787,000 | – | 6,320 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 708,528 | $29,226,780 | 100.00% |
| Meritech Capital Associates V L.L.C. | 494,236 | $20,387,235 | 6.48% |
| Sands Capital Ventures, LLC | 481,770 | $19,873,013 | 5.88% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $14,831,603 | 4.95% |
| Iron Triangle Partners LP | 666,945 | $27,511,481 | 4.02% |
| Endurant Capital Management LP | 71,044 | $2,930,565 | 2.63% |
| Brown Capital Management | 3,081,105 | $127,095,581 | 1.95% |
| RTW INVESTMENTS, LP | 1,519,956 | $62,698,185 | 1.32% |
| Parametrica Management Ltd | 15,300 | $631,125 | 1.06% |
| Capital Impact Advisors, LLC | 14,821 | $611,366 | 1.02% |